Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
37
SLGL Quote, Financials, Valuation and Earnings
Last price:
$42.42
Seasonality move
:
-13.36%
Day range:
$41.66 - $43.30
52-week range:
$4.02 - $52.26
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.19x
P/B ratio:
4.51x
Volume:
37.9K
Avg. volume:
19.3K
1-year change:
353.07%
Market cap:
$117.4M
Revenue:
$11.5M
EPS (TTM):
-$3.23
Analysts' Opinion
-
Consensus RatingSol-Gel Technologies Ltd. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $50.00, Sol-Gel Technologies Ltd. has an estimated upside of 18.65% from its current price of $42.14.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $50.00 representing 100% downside risk from its current price of $42.14.
Fair Value
-
According to the consensus of 1 analyst, Sol-Gel Technologies Ltd. has 18.65% upside to fair value with a price target of $50.00 per share.
SLGL vs. S&P 500
-
Over the past 5 trading days, Sol-Gel Technologies Ltd. has underperformed the S&P 500 by -1.18% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Sol-Gel Technologies Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Sol-Gel Technologies Ltd. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Sol-Gel Technologies Ltd. reported revenues of $400K.
Earnings Growth
-
Sol-Gel Technologies Ltd. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Sol-Gel Technologies Ltd. reported earnings per share of -$2.13.
Enterprise value:
97.6M
EV / Invested capital:
--
Price / LTM sales:
6.19x
EV / EBIT:
7.34x
EV / Revenue:
5.15x
PEG ratio (5yr expected):
-0.02x
EV / Free cash flow:
-0.82x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
7.34x
Gross Profit (TTM):
--
Return On Assets:
-24.99%
Net Income Margin (TTM):
-47.37%
Return On Equity:
-31.72%
Return On Invested Capital:
-30.42%
Operating Margin:
-1572%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.2M | $11.7M | $19M | $5.4M | $400K | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$30.1M | -$11.4M | -$10.2M | -$828K | -$6.3M | |
| EBITDA | -$30.1M | $2.1M | -- | -$828K | -- | |
| Diluted EPS | -$4.97 | -$0.34 | -$3.23 | -$0.01 | -$2.13 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $48.1M | $47.6M | $45.5M | $38M | $31.7M | |
| Total Assets | $52.8M | $51.3M | $49.9M | $43M | $34.6M | |
| Current Liabilities | $9.5M | $2.6M | $4.5M | $6.5M | $6.1M | |
| Total Liabilities | $11.4M | $3.8M | $6.7M | $8.3M | $8.6M | |
| Total Equity | $41.4M | $47.5M | $43.1M | $34.7M | $26M | |
| Total Debt | $803K | $193K | $1.2M | $922K | $592K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -$8.3M | -$7.6M | |
| Cash From Investing | -- | -- | -- | -$10.2M | $12.5M | |
| Cash From Financing | -- | -- | -- | $21.7M | -- | |
| Free Cash Flow | -$41.1M | -$36.4M | -$33.9M | -$8.4M | -$7.6M | |
SLGL
Sector
Market Cap
$117.4M
$28.1M
Price % of 52-Week High
80.64%
50%
Dividend Yield
0%
0%
Shareholder Yield
0.08%
-1.54%
1-Year Price Total Return
353.07%
-17.67%
Beta (5-Year)
1.348
0.503
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$42.75
200-day SMA
Buy
Level
$20.39
Bollinger Bands (100)
Buy
Level
24.89 - 41.49
Chaikin Money Flow
Buy
Level
1M
20-day SMA
Buy
Level
$41.88
Relative Strength Index (RSI14)
Buy
Level
53.27
ADX Line
Sell
Level
12.68
Williams %R
Neutral
Level
-42.6009
50-day SMA
Buy
Level
$38.66
MACD (12, 26)
Buy
Level
1.26
25-day Aroon Oscillator
Sell
Level
-4
On Balance Volume
Neutral
Level
2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-6.7086)
Buy
CA Score
(Annual)
Level (-0.1652)
Sell
Beneish M-Score
(Annual)
Level (3.8977)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (3.2993)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.
Stock Forecast FAQ
In the current month, SLGL has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SLGL average analyst price target in the past 3 months is $50.00.
-
Where Will Sol-Gel Technologies Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Sol-Gel Technologies Ltd. share price will rise to $50.00 per share over the next 12 months.
-
What Do Analysts Say About Sol-Gel Technologies Ltd.?
Analysts are divided on their view about Sol-Gel Technologies Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Sol-Gel Technologies Ltd. is a Sell and believe this share price will drop from its current level to $50.00.
-
What Is Sol-Gel Technologies Ltd.'s Price Target?
The price target for Sol-Gel Technologies Ltd. over the next 1-year time period is forecast to be $50.00 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SLGL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Sol-Gel Technologies Ltd. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of SLGL?
You can purchase shares of Sol-Gel Technologies Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Sol-Gel Technologies Ltd. shares.
-
What Is The Sol-Gel Technologies Ltd. Share Price Today?
Sol-Gel Technologies Ltd. was last trading at $42.42 per share. This represents the most recent stock quote for Sol-Gel Technologies Ltd.. Yesterday, Sol-Gel Technologies Ltd. closed at $42.14 per share.
-
How To Buy Sol-Gel Technologies Ltd. Stock Online?
In order to purchase Sol-Gel Technologies Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get SLGL Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SLGL
Sector
P/E ratio
--
23.88x
PEG ratio
-0.02x
-0.01x
P/B ratio
4.51x
1.82x
Price / LTM sales
6.19x
1.59x
Growth Metrics
SLGL
Sector
Revenue growth
-92.54%
4.73%
Earnings growth
-16182.44%
11.11%
Revenue (5-year growth)
-12.82%
6.46%
Earnings forecast
$0.39
-$0.18
Profitability
SLGL
Sector
Profitability FY 2024
$11.3M
$3.6M
Return on invested capital
-30.42%
-31.77%
Return on assets
-24.99%
-28.18%
Return on equity
-31.72%
-37.47%
Earnings Date
Last Earnings Date
Nov
20
Next Earnings Date
May
1
Estimated Next Earnings Date
Feb
19
Balance Sheet
SLGL
Sector
Total cash
$20.8M
$26.3M
Short term investments
$4.4M
$26M
Total assets
$35.8M
$76.9M
Long term debt
$592K
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 2
Corcept Therapeutics, Inc. [CORT] is up 5.11% over the past day.
Buy
75
AXSM alert for Jan 2
Axsome Therapeutics, Inc. [AXSM] is down 3.83% over the past day.
Sell
50
NUTX alert for Jan 2
Nutex Health, Inc. [NUTX] is down 9.63% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
